Cargando…
Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice
The in vitro and in vivo bioactivities of silibinin (SB), paclitaxel (PTX) and SB and PTX in combination (SB+PTX) against murine metastatic mammary 4T1 cancer cell line were investigated. Isobologram and combination index (CI) analyses showed that SB and PTX can function synergistically in the inhib...
Autores principales: | Ho, Bing-Ying, Lin, Chun-Hung, Apaya, Maria Karmella, Chao, Wen-Wan, Shyur, Lie-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942908/ https://www.ncbi.nlm.nih.gov/pubmed/24716145 |
Ejemplares similares
-
Deregulating the CYP2C19/Epoxy-Eicosatrienoic Acid-Associated FABP4/FABP5 Signaling Network as a Therapeutic Approach for Metastatic Triple-Negative Breast Cancer
por: Apaya, Maria Karmella, et al.
Publicado: (2020) -
Herbal Medicine and Acupuncture for Breast Cancer Palliative Care and Adjuvant Therapy
por: Liao, Guo-Shiou, et al.
Publicado: (2013) -
Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer
por: Apaya, Maria Karmella, et al.
Publicado: (2019) -
Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment
por: Wu, Tai-Na, et al.
Publicado: (2021) -
Editorial: Be positive about the negative in pharmacology: Ethnopharmacology 2022
por: Kamisah, Yusof, et al.
Publicado: (2023)